HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
HTGM
Delisted
HTGM was delisted on the 14th of June, 2023.
10 hedge funds and large institutions have $66.2K invested in HTG Molecular Diagnostics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 8 closing their positions.
Holders
10
Holders Change
-9
Holders Change %
-47.37%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$27K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$7.88K |
Top Sellers
| 1 |
1
BlackRock
New York
|
$24.4K |
| 2 |
2
Renaissance Technologies
New York
|
$0 |
| 3 |
VF
3
Virtu Financial
New York
|
$0 |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$0 |
| 5 |
5
Morgan Stanley
New York
|
$3.53K |
